Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program
January 11, 2022 07:00 ET
|
Inivata
Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program Research Triangle Park, NC, USA and Cambridge, UK, 11 January 2022 -- Inivata, a leader...
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
July 18, 2019 07:00 ET
|
Inivata
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer Prospective, interventional study...
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test
April 26, 2019 07:00 ET
|
Inivata
Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test InVisionFirst®-Lung demonstrated excellent concordance with tissue...